Australia is closely awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://giant-e-bikes395589.blogfrogs.com/312652/novo-nordisk-s-retatrutide-australia-a-potential-solution-for-losing-weight